Wnt/beta-catenin pathway: modulating anticancer immune response

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• The Wnt/β-catenin signaling pathway is evolutionarily conserved and controls fundamental cellular processes like proliferation, differentiation, and stem cell renewal.
• Aberrations in the Wnt/β-catenin pathway are implicated in various cancers, making it a key target for therapeutic interventions.
• Recent findings highlight the pathway's role in modulating the tumor microenvironment and influencing immunotherapy effectiveness.

Purpose of the Study:

• To review the critical role of the Wnt/β-catenin pathway in cancer biology.
• To discuss current and emerging therapeutic strategies targeting the Wnt/β-catenin pathway.
• To explore the pathway's impact on the tumor immune microenvironment and its implications for cancer immunotherapy.

Main Methods:

• Literature review of Wnt/β-catenin signaling in cancer.
• Analysis of WNT-directed therapeutic approaches.
• Examination of the pathway's interaction with the tumor microenvironment and immunotherapy.

Main Results:

• The Wnt/β-catenin pathway is frequently dysregulated in cancer, driving tumor growth and progression.
• Targeting Wnt/β-catenin signaling is a promising strategy for cancer treatment.
• Modulation of this pathway can impact immune cell infiltration and response to immunotherapy.

Conclusions:

• The Wnt/β-catenin pathway is a significant player in cancer pathogenesis and a viable therapeutic target.
• Understanding its role in the tumor microenvironment is crucial for optimizing cancer immunotherapy.
• Further research into WNT-directed therapies holds potential for improved cancer treatment outcomes.